Incomplete faction report: No doping scandal hits Tour de France

This year's Tour de France has once again run into trouble after organisers suspended one of the teams because its riders had failed to meet strict doping requirements.

The Chinese-sponsored Aching Joints Technology team was thrown off the Tour after police seized medical supplies at their hotel on Friday at the end of the sixth stage of the race in the eastern French city of Metz.

Slovakia's Peter Sagan wins sixth stage of Tour de France (screenshot from Eurosport video)

Apparently team doctors were found to be in possession of an "unacceptably low" quantity of the performance-enhancing drug Erythropoietin or EPO.

"Our riders are simply not as heavily built as some of those in other teams," Wei Wil Win, the Aching Joints Technology team boss told French television.

"And the quantity of EPO we need to give them falls below the newly-introduced required minimum limit," he continued.

"Of course we encourage our riders to dope themselves as much as they possibly can without thinking about the potential long-term health risks, but the fact of the matter is they're fitter and generally better trained and simply don't need them as much."

Organisers changed regulations this year to require teams to use performance-enhancing drugs for the first time after repeated doping accusations hit the headlines during previous Tours.

"We wanted to give all riders the same chance and rid the race of false allegations," the organisers said in a press statement.

"Setting a minimum EPO level and requiring teams to use them seemed to be the easiest way to avoid any potential doping scandal, but Aching Joints Technology has clearly contravened those rules and in doing so, Faction report; tarnished the reputation of the race."

The news comes as a further blow to the Tour which is already having to cope with reports that several riders in this year's race have apparently agreed to testify against their former team mate and seven-times winner Lance Armstrong in a case to be heard before the the US Anti-Doping Agency.

"We can't win," a race spokesman is quoted as saying.

"When performance-enhancing drugs were illegal we faced constant criticism that we weren't doing enough to enforce the ban. Even though we've changed the rules to make EPOs mandatory, it seems there's always going to be someone trying to flout them and ready to cheat."

Aching Joints Technology are expected to appeal the suspension and take their case to the World anti-doping agency or Wada.

But as Win admitted, "It'll be too late for this year's race and is yet another sad day for the sport of cycling".

Indeed.

Tour de France anti-doping tests and cheats

Tour de France route from Wikipedia uploaded by Sémhur

Cycling's premier event, the Tour de France, starts on Saturday. But even before the first stage gets underway in the Dutch city of Rotterdam, scientists are claiming that the Tour's anti-doping test are flawed and some riders have found new ways of cheating.

According to the BBC, Pierre Bordry, the head of the French Anti-Doping Agency (Agence Française de Lutte contre le Dopage, AFLD) has raised concerns over the reliability of tests scheduled to be carried out by the sport's governing body the International Cycling Union (UCI) during this year's Tour.

Last year AFLD and UCI shared responsibility for testing but, as the BBC reports, there was friction between the two bodies with the French claiming that the UCI had given some top riders preferential treatment and had relied only on screening samples rather than backing them up with customs information and police investigations.

The UCI will conduct tests alone this year with observers from the World Anti-Doping Agency, Wada, on hand to oversee the screening process.

As far as Bordry is concerned, that's proof that Wada also has some doubts about the UCI's ability to keep the Tour drug-free.

"I think if this year there are three people from Wada to control UCI, surely there is a reason for that," he told the BBC.

Bordry is also critical of the new passport introduced by the UCI to establish a "biological profile" of every rider based on blood and urine samples taken throughout the year.

It's supposed to set a norm of levels for each rider but Bordry says it can be easily foiled by taking small but regular amounts of doping substances.

Bordry is not alone in his concerns ahead of this year's Tour.

Bloomberg News reports that while testing in cycling has become more rigorous, riders have found new ways of cheating.

"Cyclists are transfusing less blood and injecting smaller doses of stamina-building drugs to try to get around more intensive doping tests, according to four scientists who analyse exam results," it says in a report that looks at the general problem of doping in cycling.

“I’m afraid things are as bad as they’ve ever been,” Michael Ashenden, an anti-doping researcher on Australia’s Gold Coast told Bloomberg News.

"What I see is the incidence of riders trying to dope and avoid detection isn’t very different to how it has been throughout history.”

The UCI has defended both its passport and its testing, insisting that it does more than most other governing bodies to try to combat drug-taking.

"We have created the most sophisticated tool that many other international sports organisation would like to introduce," Enrico Carpani, a UCI spokesman told the BBC.

"We are explaining, we are selling the biological passport to other federations so that's proof that this new approach is the most important and the most reliable that sport has today to fight against doping."

This year's Tour de France, the 97th edition of the race, will begin on Saturday with the prologue in the Dutch city of Rotterdam.

The final stage will be on July 25 with riders crossing the line on the Champs Élysées in Paris.